| Period Ending | Mar 30, 2013 | Dec 30, 2012 | Sep 29, 2012 | Jun 29, 2012 |
|---|
|
Total Revenue
|
78,069
|
133,507
|
314,491
|
145,359
| | Cost of Revenue | 54,690 | 102,741 | 217,779 | 98,466 | | |
Gross Profit
|
23,379
|
30,766
|
96,712
|
46,893
| |
|
Operating Expenses |
|
Research Development |
-
|
-
|
-
|
-
|
|
Selling General and Administrative | 47,224 | 61,981 | 59,416 | 46,786 |
|
Non Recurring |
-
|
-
|
-
|
-
|
|
Others |
-
|
-
|
-
|
-
|
|
|
|
Total Operating Expenses |
-
|
-
|
-
|
-
| | | |
Operating Income or Loss
|
(23,845)
|
(31,215)
|
37,296
|
107
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | 75 | 61 | 97 | 314 |
|
Earnings Before Interest And Taxes | (24,416) | (31,028) | 38,441 | 2,323 |
|
Interest Expense | 2,846 | 3,143 | 2,015 | 2,035 |
|
Income Before Tax | (27,262) | (34,171) | 36,426 | 288 |
|
Income Tax Expense | 300 | 85,286 | 5,983 | 74 |
|
Minority Interest |
-
|
-
|
-
|
-
|
|
|
|
Net Income From Continuing Ops | (28,208) | (119,331) | 31,491 | 2,116 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | | |
Net Income
|
(27,562)
|
(119,457)
|
30,443
|
214
| | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | |
Net Income Applicable To Common Shares
|
(27,562)
|
(119,457)
|
30,443
|
214
|
|
0.04(0.38%) 12:13PM EDT - Nasdaq Real Time Price